Skip to main content

Advertisement

Table 3 Baseline outcomes for all affected persons over 5 years in Australia (optimal care versus usual care)c

From: Cost-effectiveness analysis of guideline-based optimal care for venous leg ulcers in Australia

  Option 1 Option 2
Total costs in usual care group $2,831,006,652 $2,831,006,652
Total costs in optimal care group $1,200,427,937 $1,126,566,791
Total incremental costs -$1,630,578,715 -$1,704,439,861
Health system costs in usual care group $2,516,869,902 $2,516,869,902
Health system costs in optimal care group $1,128,856,145 $1,093,241,400
Incremental costs -$1,388,013,757 -$1,423,628,502
Costs by Australian government in usual care group $2,298,900,749 $2,298,900,749
Costs by Australian government in optimal care group $1,114,692,967 $1,079,078,223
Incremental costs -$1,184,207,781 -$1,219,822,526
Costs by State and Territory government in usual care group $217,969,153 $217,969,153
Costs by State and Territory government in optimal care group $14,163,177 $14,163,177
Incremental costs -$203,805,976 -$203,805,976
Out-of-pocket costs in usual care group $314,136,750 $314,136,750
Out-of-pocket costs in optimal care group $71,571,792 $33,325,391
Incremental costs -$242,564,957 -$280,811,359
Total costs of compression products in usual care groupa $487,379,273 $487,379,273
Total costs of compression products in optimal care groupb $539,765,074 $539,765,074
Incremental costs $52,385,801 $52,385,801
Costs of compression products in usual care group indirectly covered by health system $271,197,256 $271,197,256
Total costs of compression products in optimal care group covered by health system $539,765,074 $539,765,074
Incremental costs $268,567,818 $268,567,818
Costs of other dressings in usual care group $37,875,018 $37,875,018
Costs of other dressings in optimal care group $68,758,106 $68,758,106
Incremental costs $30,883,088 $30,883,088
Total QALYs in usual care group 476,090 476,090
Total QALYs in optimal care group 504,431 504,431
Incremental QALYs 28,341 28,341
  1. aTotal costs of compression products in usual care group were covered by out-of-pocket expenditure and government’s funding to health professionals
  2. bCosts of compression products in optimal care group were covered by Australian government
  3. cCosts were measured in 2015 Australian dollars. Baseline outcomes by State and Territory are summarised in Additional file 1 Tables S6 and S7. Costs per person and QALY per person could not be calculated by dividing the total by the number of affected persons as not all affected persons received treatment and prevention for the entire 5 years in this model. By the end of 2020, patients who developed VLUs in 2016 would incur more costs associated with treatment and prevention than those who developed VLUs in 2017. Expected costs and QALYs per person over 5 years if the person received treatment and prevention for 5 years are summarised in Additional file 1: Tables S8 and S9